J. Stránský

发表

Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic

A. Chlumská, J. Stránský, M. Horejsová, 1997, Infection.

Iron Overload and HFE Gene Mutations in Czech Patients with Chronic Liver Diseases

J. Horák, K. Krátká, J. Stránský, 2012, Disease markers.

High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic

J. Vránová, J. Horák, K. Krátká, 2008, The British journal of dermatology.

Are Hepatitis C Infection and C282Y Mutation in Hemochromatosis Gene Independent Factors for Porphyria cutanea tarda?

J. Stránský, E. Žďárský, H. Michalíková, 2002, Dermatology.

Geographical differences in prevalence of hepatitis C virus infection in PCT (porphyria cutanea tarda)

J. Stránský, E. Žďárský, L. Malina, 1997, The British journal of dermatology.

[The discovery of hepatitis G virus].

J. Stránský, 1996, Casopis lekaru ceskych.

Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.

J. Horák, J. Stránský, I. Půtová, 2000, Acta virologica.

Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.

J. Stránský, M. Zichová, M. Vodák, 1993, Acta virologica.

[Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].

J. Horák, M. Rýzlová, J. Stránský, 2002, Vnitrni lekarstvi.

[A relapsing and protracted form of viral hepatitis A: comparison of adults and children].

J. Kynčl, J. Stránský, E. Honzáková, 1995, Vnitrni lekarstvi.

Prevalence of anti-delta antibodies in chronic HBsAg carriers in czechoslovakia

Z. Horák, J. Stránský, P. Chalupa, 1989, Infection.